6201 - 6250 of 8816 Results
Title
Year
-
OPENTitle: Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity studyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2101Best OA location URL: https://doi.org/10.1002/brb3.2101Citation Count: 13
-
OPENTitle: Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-27204-9Best OA location URL: https://escholarship.org/uc/item/0nc5b6htCitation Count: 42
- The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease2021OPENTitle: The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 10Start Page: 3114End Page: 3125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab191Best OA location URL: https://academic.oup.com/brain/article-pdf/144/10/3114/41381603/awab191.pdfCitation Count: 138
- Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerability2021OPENTitle: Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerabilityJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab269Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/4/fcab269/41729026/fcab269.pdfCitation Count: 48
-
OPENTitle: Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease PatientsJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.763777Best OA location URL: https://doi.org/10.3389/fnmol.2021.763777Citation Count: 16
-
OPENTitle: Differential Effects of Pathological Beta Burst Dynamics Between Parkinson’s Disease Phenotypes Across Different MovementsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.733203Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.733203/pdfCitation Count: 26
-
OPENTitle: Reliability and validity of the novel Italian version of the 14-item Resilience Scale (RS-14) in adultsJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 5Start Page: 3079End Page: 3087Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10072-021-05784-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-021-05784-0.pdfCitation Count: 7
-
OPENTitle: A real-world study of wearable sensors in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00248-wBest OA location URL: https://www.nature.com/articles/s41531-021-00248-w.pdfCitation Count: 47
- Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis2021OPENTitle: Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysisJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00247-xBest OA location URL: https://www.nature.com/articles/s41531-021-00247-x.pdfCitation Count: 22
- Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease2021OPENTitle: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00250-2Best OA location URL: https://www.nature.com/articles/s41531-021-00250-2.pdfCitation Count: 15
-
OPENTitle: The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat ModelsJournal Name: BiomoleculesPublisher: MDPI AGVol: 11Issue #: 11Start Page: 1685End Page: 1685Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom11111685Best OA location URL: https://www.mdpi.com/2218-273X/11/11/1685/pdf?version=1636779345Citation Count: 7
-
OPENTitle: Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.729635Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.729635/pdfCitation Count: 15
- Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial2021OPENTitle: Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2408End Page: 2412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28702Best OA location URL: https://doi.org/10.1002/mds.28702Citation Count: 16
- International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease2021OPENTitle: International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2583End Page: 2594Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28706Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28706Citation Count: 106
-
OPENTitle: Mitochondrial Defects in Fibroblasts of Pathogenic MAPT PatientsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2021.765408Best OA location URL: https://doi.org/10.3389/fcell.2021.765408Citation Count: 5
-
OPENTitle: Stability Evaluation of Brain Changes in Parkinson's Disease Based on Machine LearningJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2021.735991Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncom.2021.735991/pdfCitation Count: 9
-
OPENTitle: Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's diseaseJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 24Issue #:Start Page: 100817End Page: 100817Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100817Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100817Citation Count: 20
-
OPENTitle: Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian CohortsJournal Name: Journal of Clinical MedicinePublisher: MDPI AGVol: 10Issue #: 21Start Page: 5085End Page: 5085Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jcm10215085Best OA location URL: https://www.mdpi.com/2077-0383/10/21/5085/pdf?version=1635753758Citation Count: 12
-
OPENTitle: Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMIJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00241-3Best OA location URL: https://www.nature.com/articles/s41531-021-00241-3.pdfCitation Count: 43
-
OPENTitle: Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson’s Disease?Journal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 21Start Page: 11522End Page: 11522Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms222111522Best OA location URL: https://www.mdpi.com/1422-0067/22/21/11522/pdf?version=1635236511Citation Count: 10
-
OPENTitle: Kinetics of alpha-synuclein depletion in three brain regions following conditional pan-neuronal inactivation of the encoding gene (Snca) by tamoxifen-induced Cre-recombination in adult miceJournal Name: Transgenic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 6Start Page: 867End Page: 873Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11248-021-00286-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11248-021-00286-3.pdfCitation Count: 3
-
OPENTitle: COVID-19 Vaccination Reactogenicity in Persons With Multiple SclerosisJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000001104Best OA location URL: https://nn.neurology.org/content/nnn/9/1/e1104.full.pdfCitation Count: 37
-
OPENTitle: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01282-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01282-8Citation Count: 185
-
OPENTitle: Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label StudyJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 693End Page: 709Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00251-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00251-6.pdfCitation Count: 23
-
OPENTitle: Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 739End Page: 751Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00256-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00256-1.pdfCitation Count: 11
-
OPENTitle: Prevalence and characteristics of the aberrant anterior tibial artery: a single-center magnetic resonance imaging study and scoping reviewJournal Name: BMC Musculoskeletal DisordersPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12891-021-04801-9Best OA location URL: https://bmcmusculoskeletdisord.biomedcentral.com/track/pdf/10.1186/s12891-021-04801-9Citation Count: 5
-
OPENTitle: Mapping autonomic, mood and cognitive effects of hypothalamic region deep brain stimulationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 9Start Page: 2837End Page: 2851Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab170Best OA location URL: https://academic.oup.com/brain/article-pdf/144/9/2837/40880314/awab170.pdfCitation Count: 21
-
OPENTitle: Mental health in people with Parkinson’s disease during the COVID-19 pandemic: potential for targeted interventions?Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00238-yBest OA location URL: https://www.nature.com/articles/s41531-021-00238-y.pdfCitation Count: 20
-
OPENTitle: Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2344Best OA location URL: https://doi.org/10.1002/brb3.2344Citation Count: 13
-
OPENTitle: Herpesvirus Infections and Risk of Parkinson’s DiseaseJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 20Issue #: 2-3Start Page: 97End Page: 103Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000512874Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8552529Citation Count: 24
-
OPENTitle: Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 109333End Page: 109333Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.109333Best OA location URL: http://www.cell.com/article/S2211124721007099/pdfCitation Count: 34
- Predicting PY motif-mediated protein-protein interactions in the Nedd4 family of ubiquitin ligases2021OPENTitle: Predicting PY motif-mediated protein-protein interactions in the Nedd4 family of ubiquitin ligasesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0258315End Page: e0258315Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0258315Best OA location URL: https://doi.org/10.1371/journal.pone.0258315Citation Count: 16
-
OPENTitle: Relationships between Mitochondrial Function, AMPK, and TORC1 Signaling in Lymphoblasts with Premutation Alleles of the FMR1 GeneJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 19Start Page: 10393End Page: 10393Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms221910393Best OA location URL: https://www.mdpi.com/1422-0067/22/19/10393/pdf?version=1632737629Citation Count: 4
-
OPENTitle: Severity of Downgaze Palsy in the Context of Disease Duration Could Estimate Survival Duration in Patients With Progressive Supranuclear PalsyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.736784Best OA location URL: https://escholarship.org/uc/item/4rt0n68qCitation Count: 4
-
OPENTitle: Connectivity correlates to predict essential tremor deep brain stimulation outcome: Evidence for a common treatment pathwayJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 32Issue #:Start Page: 102846End Page: 102846Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2021.102846Best OA location URL: https://doi.org/10.1016/j.nicl.2021.102846Citation Count: 43
- Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption2021OPENTitle: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruptionJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-26066-5Best OA location URL: https://www.nature.com/articles/s41467-021-26066-5.pdfCitation Count: 177
-
OPENTitle: Humanized Biomimetic Nanovesicles for Neuron TargetingJournal Name: Advanced SciencePublisher: WileyVol: 8Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202101437Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202101437Citation Count: 26
- Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson Disease2021OPENTitle: Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 14Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1212/wnl.0000000000012633Best OA location URL: https://n.neurology.org/content/neurology/97/14/e1404.full.pdfCitation Count: 24
-
OPENTitle: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.705407Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.705407/pdfCitation Count: 67
-
OPENTitle: A six-metabolite panel as potential blood-based biomarkers for Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00239-xBest OA location URL: https://www.nature.com/articles/s41531-021-00239-x.pdfCitation Count: 43
-
OPENTitle: Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomesJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-021-00513-5Best OA location URL: https://www.nature.com/articles/s41746-021-00513-5.pdfCitation Count: 78
-
OPENTitle: Salivary Lactoferrin Expression in a Mouse Model of Alzheimer’s DiseaseJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 749468End Page: 749468Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2021.749468Best OA location URL: https://doi.org/10.3389/fimmu.2021.749468Citation Count: 19
-
OPENTitle: Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.723476Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.723476/pdfCitation Count: 7
- Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression2021OPENTitle: Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2444End Page: 2446Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28715Best OA location URL: https://doi.org/10.1002/mds.28715Citation Count: 50
-
OPENTitle: Brain proteome-wide association study implicates novel proteins in depression pathogenesisJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 24Issue #: 6Start Page: 810End Page: 817Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-021-00832-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8530461Citation Count: 139
-
OPENTitle: Copy Number Variation in Parkinson's Disease: An Update from Sub‐Saharan AfricaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2442End Page: 2444Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28710Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8530875Citation Count: 4
-
OPENTitle: Sex differences for phenotype in pathologically defined dementia with Lewy bodiesJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 92Issue #: 7Start Page: 745End Page: 750Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2020-325668Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8530264Citation Count: 41
-
OPENTitle: Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagyJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.72328Best OA location URL: https://doi.org/10.7554/elife.72328Citation Count: 132
-
OPENTitle: KYNA/Ahr Signaling Suppresses Neural Stem Cell Plasticity and Neurogenesis in Adult Zebrafish Model of Alzheimer’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 10Start Page: 2748End Page: 2748Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10102748Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2021-01487%22Citation Count: 18
-
OPENTitle: Cluster Analysis of Categorical Variables of Parkinson’s Disease PatientsJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 10Start Page: 1290End Page: 1290Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11101290Best OA location URL: https://www.mdpi.com/2076-3425/11/10/1290/pdfCitation Count: 5